Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...

While technology stocks get a lot of attention from the media, there are a lot of attractive options in the consumer goods ...

Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...

This approval marks a significant milestone as ZYN is now one of the few flavored ... regulatory trends and consumer preferences. The price objective of $143 reflects a premium valuation ...

This month 20 products from the popular ZYN brand became the first such pouches to be “authorized” by the U.S. Food and Drug Administration. While this falls short of the FDA’s designation ...

The Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by the regulator for the fast-growing nicotine pouches segment. The ...

And it's not chewing tobacco, because there's no tobacco or spitting required. It's called Zyn, a brand of nicotine pouches that have gained popularity, especially among younger demographics.

WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.

Let freedom ryng: On Thursday, the Food and Drug Administration (FDA) authorized the marketing of 20 Zyn nicotine pouch products, allowing them to be legally sold by tobacco retailers nationwide ...